Systematic review of the psychological consequences of false-positive screening mammograms

Health Technology Assessment

Volumn 17, Issue 13, 2013, Pages 1-86

  Bond, M ^a   Pavey, T ^a   Welch, K ^b   Cooper, C ^a   Garside, R ^a   Dean, S ^a   Hyde, C ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b Karen Welch Information Consultancy   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTRESS SYNDROME; FALSE POSITIVE RESULT; FAMILY HISTORY; FEMALE; FOLLOW UP; HEALTH IMPACT ASSESSMENT; HEALTH PROGRAM; HUMAN; HUMAN TISSUE; MAMMOGRAPHY; MEDICAL HISTORY; MEDICAL INFORMATION; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; QUALITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SCREENING TEST; SYSTEMATIC REVIEW; UNITED KINGDOM; WOMEN'S HEALTH;

EID: 84876077361     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta17130     Document Type: Article

References (130)

1. Forrest P. Breast cancer screening. Report to the Health Ministers of England, Wales, Scotland and Northern Ireland. London: HMSO; 1986.
2. The NHS Information Centre PHIT. Breast screening results from the NHSBSP 2009-10. 2011. URL: www.cancerscreening.nhs.uk/breastscreen/statistics.html (cited 28 March 2011).
3. World Health Organisation (WHO) International Agency for Research on Cancer. Breast cancer screening. International Agency for Research on Cancer. WHO; 2002.
4. Cancer Research UK. Breast cancer-UK incidence statistics. 2010. URL: http://info.cancerresearchuk.org (cited 4 May 2010).
5. Beral V, Banks E, Reeves G, Wallis M. Hormone replacement therapy and high incidence of breast cancer between mammographic screens. Lancet 1997;349:1103-1104. http://dx.doi.org/10.1016/S0140-6736(05)62328-8
6. Quinn MJ, Cooper N, Rachet B, Mitry E, Coleman MP. Survival from cancer of the breast in women in England and Wales up to 2001. Br J Cancer 2008;99(Suppl. 1):S53-S55. http://dx.doi.org/10.1038/sj.bjc.6604587
7. Parsa P, Parsa B. Effects of reproductive factors on risk of breast cancer: a literature review. Asian Pac J Cancer Prev 2009;10:545-550.
8. Office for National Statistics. Cancer statistics registrations: registrations of cancer diagnosed in 2007, England. London: National Statistics; 2010.
9. ISD Scotland. ISD Cancer Information Programme. 2009. URL: www.isdscotland.org (cited 4 November 2012).
10. Welsh Cancer Intelligence and Surveillance Unit. Cancer incidence in Wales. 2010. URL: www.wales.nhs.uk (cited 4 November 2010).
11. Office for National Statistics. Breast Cancer: incidence rates rise, mortality rates fall. 2011. RL: www.statistics.gov.uk/CCI/nugget.asp?ID=575 (cited 29 March 2011).
12. Autier P, Boniol M, Gavin A, Vatten LJ. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ 2011;343.
13. U.S. Preventative Services Task Force. Addendum and correction: screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2010;152:688.
14. Bleyer A. US breast cancer mortality is consistent with European data. BMJ 2011;343.
15. de Koning H. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ 2011;343:d4411. http://dx.doi.org/10.1136/bmj.d4411
16. Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2011;1:CD001877.
17. Shapiro S, Venet W, Strax P. Selection, follow-up, and analysis in the health insurance plan study: a randomized trial with breast cancer screening. J Natl Cancer Inst Monogr 1985;67:65-74.
18. Strax P. Mass screening for breast cancer. Rev Fr Gynecol Obstet 1973;68:457-466. cancer: the Swedish trial. Radiology 1981;138:219-222.
19. Fink R, Shapiro S, Roester R. Impact of efforts to increase participation in repetitive screenings for early breast cancer detection. Am J Public Health 1972;62:328-36. http://dx.doi.org/10.2105/ AJPH.62.3.328
20. Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ 1988;297:943-8. http://dx.doi.org/10.1136/bmj.297.6654.943
21. Andersson I. Radiographic screening for breast carcinoma. II. Prognostic considerations on the basis of a short-term follow-up. Acta Radiol Diagn 1981;22:227-33. http://dx.doi. org/10.1111/j.1748-1716.1981.tb06887.x
22. Andersson I. Radiographic screening for breast carcinoma. I. Program and primary findings in 45-69 year old women. Acta Radiol Diagn 1981;22:185-94.
23. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Scand J Caring Sci 2002;359:909-19.
24. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A,Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radio Clin North Am 1992;30:187-210.
25. Tabar L, Gad A.Screening for breast cancer: the Swedish trial. Radiology 1981;138:219-22
26. Tabar L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Grontoft O, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health & Welfare. Lancet 1985;i:829-32.
27. Alexander F, Roberts MM, Lutz W, Hepburn W. Randomisation by cluster and the problem of social class bias. J Epidemiol Community Health 1989;43:29-36. http://dx.doi.org/10.1136/jech.43.1.29
28. Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, et al. The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer 1994;70:542-548. http://dx.doi.org/10.1038/bjc.1994.342
29. Alexander FE, Anderson TJ, Brown HK, Forrest APM, Hepburn W, Kirkpatrick AE, et al. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet 1999;353:1903-1908. http://dx.doi.org/10.1016/S0140-6736(98)07413-3
30. Baines CJ. The Canadian National Breast Screening Study: a perspective on criticisms. Ann Intern Med 1994;120:326-334.
31. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study - 2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2000;92:1490-1499. http://dx.doi.org/10.1093/jnci/92.18.1490
32. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study - 1: breast cancer mortality after 11 to 16 years of follow-up. Ann Intern Med 2002;137:E-305.
33. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study: update on breast cancer mortality. J Natl Cancer Inst Monogr 1997;22:37-41.
34. Frisell J, Lidbrink E, Hellstrom L, Rutqvist LE. Follow up after 11 years - update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat 1997;45:263-270. http://dx.doi.org/10.1023/A:1005872617944
35. Frisell J, Glas U, Hellstrom L, Somell A. Randomized mammographic screening for breast cancer in Stockholm. Design, first round results and comparisons. Breast Cancer Res Treat 1986;8:45-54. http://dx.doi.org/10.1007/BF01805924
36. Frisell J, Eklund G, Hellstrom L, Lidbrink E, Rutqvist LE, Somell A. Randomized study of mammography screening - preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 1991;18:49-56. http://dx.doi.org/10.1007/BF01975443
37. Frisell J, Eklund G, Hellstrom L, Glas U, Somell A. The Stockholm breast cancer screening trial - 5-year results and stage at discovery. Breast Cancer Res Treat 1989;13:79-87. http://dx.doi.org/10.1007/BF01806553
38. Bjurstam N, Bjorneld L, Warwick J, Sala E, Duffy SW, Nystrom L, et al. The Gothenburg Breast Screening Trial. Cancer 2003;97:2387-2396. http://dx.doi.org/10.1002/cncr.11361
39. Bjurstam N, Bjorneld L, Duffy SW, Smith TC, Cahlin E, Eriksson O, et al. The Gothenburg breast screening trial. Cancer 1997;80:2091-2099.
40. UK Trial. First results on mortality reduction in the UK Trial of Early Detection of Breast Cancer. UK Trial of Early Detection of Breast Cancer Group. Lancet 1988;[0140-6736 (Print)].
41. Moss S. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group. J Med Screen 1999;6:144-148.
42. Moss S, Waller M, Anderson TJ, Cuckle H (writing committee for the Trial Management Group). Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures. Br J Cancer 2005;92:955-960. http://dx.doi.org/10.1038/sj.bjc.6602395
43. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L, et al. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. 2006;368:2053-2060.
44. Moss S, Thomas I, Evans A, Thomas B, Johns L. Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years. Br J Cancer 2005;92:949-954. http://dx.doi.org/10.1038/sj.bjc.6602396
45. Kopans DB, Smith RA, Duffy SW. Mammographic Screening and Overdiagnosis. Radiology 2011;260:616-620. http://dx.doi.org/10.1148/radiol.11110716
46. Otto SJ, Fracheboud J, Looman C, Broeders M, Boer R, Hendriks J, et al. Initiation of populationbased mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 2003;361:1411-1417. http://dx.doi.org/10.1016/S0140-6736(03)13132-13137
47. Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen THH, et al. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 2010;17:25-30. http://dx.doi.org/10.1258/jms.2009.009094
48. Wald NJ, Law MR, Duffy SW. Breast screening saves lives. BMJ 2009;339.
49. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. 2005;353:1784-1792.
50. Duffy S. Re: Estimate of breast screening benefit was 6 times too large. 2009. URL: www.bmj.com/cgi/eletters/338/jan27_2/b86 (cited 11 October 2011).
51. Marteau TM, Cook R, Kidd J, Michie S, Johnston M, Slack J, et al. The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study. Prenat Diagn 1992;12:205-214. http://dx.doi.org/10.1002/pd.1970120309
52. French DP, Maissi E, Marteau TM. The psychological costs of inadequate cervical smear test results: three-month follow-up. Psychooncology 2006;15:498-508. http://dx.doi.org/10.1002/pon.980
53. Lampic C, Thurfjell E, Bergh J, Sjoden P-O. Short- and long-term anxiety and depression in women recalled after breast cancer screening. Eur J Cancer 2001;37:463-469. http://dx.doi.org/10.1016/S0959-8049(00)00426-3
54. Scaf-Klomp W, Sanderman R, van de Wiel HB, Otter R, van den Heuvel WJ. Distressed or relieved? Psychological side effects of breast cancer screening in The Netherlands. J Epidemiol Community Health 1997;51:705-710. http://dx.doi.org/10.1136/jech.51.6.705
55. Sutton S, Saidi G, Bickler G, Hunter J. Does routine screening for breast cancer raise anxiety? Results from a three wave prospective study in England. J Epidemiol Community Health 1995;49:413-418. http://dx.doi.org/10.1136/jech.49.4.413
56. Aro AR, Pilvikki Absetz S, van Elderen TM, van der Ploeg E, van der Kamp LJT. False-positive findings in mammography screening induces short-term distress - breast cancer-specific concern prevails longer. Eur J Cancer 2000;36:1089-1097. http://dx.doi.org/10.1016/S0959-8049(00)00065-4
57. Gram IT, Lund E, Slenker SE. Quality of life following a false positive mammogram. Br J Cancer 1990;62:1018-1022. http://dx.doi.org/10.1038/bjc.1990.430
58. Burman ML, Taplin SH, Herta DF, Elmore JG. Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization. Ann Intern Med 1999;131:1-6.
59. Brett J, Austoker J. Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance. J Public Health 2001;23:292-300. http://dx.doi.org/10.1093/pubmed/23.4.292
60. Lampic C, Thurfjell E, Sjoden P-O. The influence of a false-positive mammogram on a woman's subsequent behaviour for detecting breast cancer. Eur J Cancer 2003;39:1730-1737. http://dx.doi.org/10.1016/S0959-8049(02)00451-3
61. McCann J, Stockton D, Godward S. Impact of false-positive mammography on subsequent screening attendance and risk of cancer. Breast Cancer Res 2002;4:R11. http://dx.doi.org/10.1186/bcr455
62. Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med 2007;146:502-510.
63. NHS Breast Screening Programme. Quality assurance guidelines for breast cancer screening radiology. Wilson R, Liston J, editors. 59. 2011. Sheffield: NHS Cancer Screening Programmes; 2011.
64. NHS Breast Screening Programme. Clinical guidelines for breast cancer screening assessment. Liston J, Wilson R, editors. 49. 2010. Sheffield: NHS Cancer Screening Programmes; 2011.
65. NHS Cancer Screening Programme. Quality assurance guidelines for surgeons in breast cancer screening. Sibbering M, Watkins R, Winstanely J, Patnick J, editors. 20. 2009. Sheffield: NHS Cancer Screening Programme; 2011.
66. NHS Breast Screening Programme. Quality assurance guidelines for clinical nurse specialists in breast cancer screening. 29. 2008. Sheffield: NHS Cancer Screening Programmes; 2011.
67. Cockburn J, De Luise T, Hurley S, Clover K. Development and validation of the PCQ: a questionnaire to measure the psychological consequences of screening mammography. So Sci Med 1992;34:1129-1134. http://dx.doi.org/10.1016/0277-9536(92)90286-Y
68. Lerman C, Trock B, Rimer BK, Boyce A, Jepson C, Engstrom PF. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 1991;114:657-661.
69. Lerman C, Trock B, Rimer BK, Jepson C, Brody D, Boyce A. Psychological side effects of breast cancer screening. Health Psychol 1991;10:259-267. http://dx.doi.org/10.1037/0278-6133.10.4.259
70. Watson M, Lloyd S, Davidson J, Meyer L, Eeles R, Ebbs S, et al. The impact of genetic counseling on risk perception and mental health in women with a family history of breast cancer. Br J Cancer 1999;79:868-874. http://dx.doi.org/10.1038/sj.bjc.6690139
71. Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med 1997;4:92-100. http://dx.doi.org/10.1207/s15327558ijbm0401_6
72. Goldberg D. The detection of psychiatric illness by questionnaire. Oxford: Oxford University Press; 1972.
73. Goldberg D, Williams P. A User's guide to the General Health Questionnaire. London: NFER-Nelson; 1988.
74. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-370. http://dx.doi.org/10.1111/j.1600-0447.1983.tb09716.x
75. Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol 1994;67:1063-1078. http://dx.doi.org/10.1037/0022-3514.67.6.1063
76. Speilberger C. Manual for the State-Trait Anxiety Inventory: STAI (form Y). Palo Alto, CA: Consulting Psychologists Press; 1983.
77. NHS Centre for Reviews and Dissemination. Systematic reviews: CRD's guidance for undertaking reviews in health care. York: NHS Centre for Reviews and Dissemination; 2009.
78. nd edn. London: BMJ; 2001. http://dx.doi.org/10.1002/9780470693926
79. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339.
80. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191-1194. http://dx.doi.org/10.1016/S0140-6736(00)04337-3
81. Elm Ev, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335:806-808. http://dx.doi.org/10.1136/bmj.39335.541782.AD
82. Brett J, Bankhead C, Henderson B, Watson E, Austoker J. The psychological impact of mammographic screening. A systematic review. Psycho Oncol 2005;14:917-938. http://dx.doi.org/10.1002/pon.904
83. Greenhalgh T, Peacock R. Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources. BMJ 2005;33:1064-1065. http://dx.doi.org/10.1136/bmj.38636.593461.68
84. Bankhead CR, Brett J, Bukach C, Webster P, Stewart-Brown S, Munafo M, et al. The impact of screening on future health-promoting behaviours and health beliefs: a systematic review. Health Technol Assess 2003;7(42).
85. Salz T, Richman AR, Brewer NT. Meta-analyses of the effect of false-positive mammograms on generic and specific psychosocial outcomes. Psycho Oncol 2010;19:1026-1034. http://dx.doi.org/10.1002/pon.1676
86. Hafslund B, Nortvedt MW. Mammography screening from the perspective of quality of life: a review of the literature. Scand J Caring Sci 2009;23:539-548. http://dx.doi.org/10.1111/j.1471-6712.2008.00634.x
87. Armstrong K, Moye E, Williams S, Berlin JA, Reynolds EE. Clinical guidelines. Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med 2007;146:516.
88. Meystre-Agustoni G, Paccaud F, Jeannin A, Dubois-Arber F. Anxiety in a cohort of Swiss women participating in a mammographic screening programme. J Med Screen 2001;8:213-219. http://dx.doi.org/10.1136/jms.8.4.213
89. Beck AT, Erbaugh J, Ward CH, Mock J, Mendelsohn M. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571. http://dx.doi.org/10.1001/archpsyc.1961.01710120031004
90. Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults -evaluation of a short-form of the CES-D. Am J Prev Med 1994;10:77-84.
91. Boer H. Psychological effects of breast cancer screening. Twente: University of Twente; 1993.
92. Goldberg DP. Manual of the General Health Questionnaire. Windsor: NFER-Nelson Publishing; 1978.
93. Walker LG, Cordiner CM, Gilbert FJ, Needham G, Deans HE, Affleck IR, et al. How distressing is attendance for routine breast screening? Psycho Oncol 1994;3:299-304. http://dx.doi.org/10.1002/pon.2960030406
94. Derogatis L, Lipman RS, Rickels K, Uhlenhut E, Covi L. Hopkins Symptom Checklist (HSCL) - a selfreport symptom inventory. Behav Sci 1974;19:1-15. http://dx.doi.org/10.1002/bs.3830190102
95. Kellner R. Abridged manual of the illness attitude scales. Albuquerque, NM: University of New Mexico; 1987.
96. Horowitz M, Wilner N, Alvarez W. Impact of event scale - measure of subjective stress. Psychosom Med 1979;4:209-218.
97. Kessler RC, Andrews G, Colpe LJ, Hiripi E, Mroczek DK, Normand SLT, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med 2002;32:959-976. http://dx.doi.org/10.1017/S0033291702006074
98. McNaire D, Lorr M, Droppleman LF. Manual for the profiles of moods scale. San Diego, CA: Educational and Industrial Testing Services; 1971.
99. Rakowski W, Andersen M, Stoddard AM, Urban N, Rimer BK, Lane DS, et al. Confirmatory analysis of opinions regarding the pros and cons of mammography. Health Psychology 1997;16:433-442. http://dx.doi.org/10.1037/0278-6133.16.5.433
100. Derogatis L. Administration, scoring and procedures manual 1 to the (revised) version. Baltimore, MD: Johns Hopkins University School of Medicine; 1977.
101. Tyndel S, Austoker J, Henderson BJ, Brain K, Bankhead C, Clements A, et al. What is the psychological impact of mammographic screening on younger women with a family history of breast cancer? Findings from a prospective cohort study by the PIMMS Management Group. J Clin Oncol 2007;25:3823-3830. http://dx.doi.org/10.1200/JCO.2007.11.0437
102. Brain K, Henderson BJ, Tyndel S, Bankhead C, Watson E, Clements A, et al. Predictors of breast cancer-related distress following mammography screening in younger women on a family history breast screening programme. Psychooncology 2008;17:1180-1188. http://dx.doi.org/10.1002/pon.1355
103. Brett J, Austoker J, Ong G. Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multi-centre follow-up study comparing different breast screening result groups five months after their last breast screening appointment. J Public Health 1998;20:396-403. http://dx.doi.org/10.1093/oxfordjournals.pubmed.a024793
104. Ong G, Austoker J, Brett J. Breast screening: adverse psychological consequences one month after placing women on early recall because of a diagnostic uncertainty. A multicentre study. J Med Screen 1997;4:158-168.
105. Ellman R, Angeli N, Christians A, Moss S, Chamberlain J, Maguire P. Psychiatric morbidity associated with screening for breast cancer. Br J Cancer 1989;60:781-784. http://dx.doi.org/10.1038/bjc.1989.359
106. Bull AR, Campbell MJ. Assessment of the psychological impact of a breast screening programme. Br J Radiol 1991;64:510-515. http://dx.doi.org/10.1259/0007-1285-64-762-510
107. Clements A, Tyndel S, Henderson B, Brain K, Watson E, Austoker J, et al. 'More positive about mammography' - reactions of women to a false positive recall: a qualitative study of women at risk of familial breast cancer. Breast Cancer Res 2008;10:90. http://dx.doi.org/10.1186/bcr1974
108. O'Sullivan I, Sutton S, Dixon S, Perry N. False positive results do not have a negative effect on reattendance for subsequent breast screening. J Med Screen 2001;8:145-148. http://dx.doi.org/10.1136/jms.8.3.145
109. Orton M, Fitzpatrick R, Fuller A, Mant D, Mlynek C, Thorogood M. Factors affecting women's response to an invitation to attend for a second breast cancer screening examination. Br J Gen Pract 1991;41:320-322.
110. Ong G, Austoker J. Recalling women for further investigation of breast screening: women's experiences at the clinic and afterwards. J Public Health Med 1997;19:29-36. http://dx.doi.org/10.1093/oxfordjournals.pubmed.a024582
111. Ong G, Austoker J, Brouwer A. Evaluation of the written information sent to women who are called back for further investigation of breast screening in the UK. Health Education Journal 1996;55:413-429. http://dx.doi.org/10.1177/001789699605500407
112. Austoker J, Ong G. Written information needs of women who are recalled for further investigation of breast screening: results of a multicentre study. J Med Screen 1994;1:238-244.
113. Smith S, Botha JL, Goosey R, Daintith H. Audit of user satisfaction with the Leicestershire Breast Screening Service - women attending for assessment of abnormal mammograms. J Public Health Med 1991;13:166-171.
114. Ong G, Austoker J, Brouwer A, Programme NHSB. Guidelines on improving the quality of the written information sent to women who are recalled for assessment. NHSBSP Publication no. 38. NHSBSP; 1998.
115. Meldrum P, Turnbull D, Dobson HM, Colquhoun C, Gilmour WH, McIlwaine GM. Tailored written invitations for second round breast cancer screening: a randomised controlled trial. J Med Screen 1994;1:245-248.
116. Brodersen J, Thorsen H, Cockburn J. The adequacy of measurement of short and long-term consequences of false-positive screening mammography. J Med Screen 2004;11:39-44. http://dx.doi.org/10.1258/096914104772950745
117. Brodersen J, Thorsen H, Kreiner S. Validation of a condition-specific measure for women having an abnormal screening mammography. Value Health 2007;10:294-304. http://dx.doi.org/10.1111/j.1524-4733.2007.00184.x
118. Brodersen J, McKenna SP, Doward LC, Thorsen H. Measuring the psychosocial consequences of screening. Health Qual Life Outcomes 2007;5:3. http://dx.doi.org/10.1186/1477-7525-5-3
119. Brodersen J, Thorsen H, Anderson JS. Short-term and long-term psychosocial consequences of false positive screening mammography - development of two new questionnaire based on the psychological consequences questionnaire (the PCQ). Value Health 2004;7:786-787. http://dx.doi.org/10.1016/S1098-3015(10)66105-0
120. Wardle J, Pope R. The psychological costs of screening for cancer. J Psychosom Res 1992;36:609-624. http://dx.doi.org/10.1016/0022-3999(92)90051-3
121. Chalmers K, Thomson K. Coming to terms with the risk of breast cancer: perceptions of women with primary relatives with breast cancer. 1996;6:256-282.
122. Scaf-Klomp W, van Sonderen FL, Stewart R, van Dijck JA, van den Heuvel WJ. Compliance after 17 years of breast cancer screening. J Med Screen 1995;2:195-199.
123. Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F, et al. Evaluating non-randomised intervention studies. Health Technol Assess 2003;7(27).
124. Mays N, Pope C. Qualitative research: rigour and qualitative research. BMJ 1995;311:109-112. http://dx.doi.org/10.1136/bmj.311.6997.109
125. Popay J, Rogers A, Williams G. Rationale and standards for the systematic review of qualitative literature in health services research. Qual Health Res 1998;8:341-351. http://dx.doi.org/10.1177/104973239800800305
126. Noblit GW, Hare RD. Meta-ethnography: synthesizing qualitative studies. Newbury Park, CA: Sage; 1988.
127. Britten N, Campbell R, Pope C, Donovan J, Morgan M, Pill R. Using meta ethnography to synthesise qualitative research: a worked example. J Health Serv Res Policy 2002;7:209-215. http://dx.doi.org/10.1258/135581902320432732
128. Garside R, Britten N, Stein K. The experience of heavy menstrual bleeding: a systematic review and meta-ethnography of qualitative studies. J Adv Nurs 2008;63:550-562. http://dx.doi.org/10.1111/j.1365-2648.2008.04750.x
129. Rodgers M, Sowden A, Pettigrew M, Arai L, Roberts H, Britten N, et al. Testing methodological guidance on the conduct of narrative synthesis in systematic reviews. 2009. URL: http://evi.sagepub.com (cited 12 June 2009).
130. Oliver S, Harden A, Rees R, Shepherd J, Brunton G, Oakley A. Young people and mental health: novel methods for systematic review of research on barriers and facilitators. Health Educ Res 2008;23:770-790. http://dx.doi.org/10.1093/her/cym038